Michael Gandy

786 total citations
25 papers, 532 citations indexed

About

Michael Gandy is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Gandy has authored 25 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Gandy's work include Glycosylation and Glycoproteins Research (4 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Michael Gandy is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Michael Gandy collaborates with scholars based in United Kingdom, Australia and United States. Michael Gandy's co-authors include Keith A. Stubbs, Colin L. Raston, Matthew Piggott, Jane Starczynski, Neil Atkey, Joshua S. Mylne, Jonathan M. Brotchie, Tom H. Johnston, Aleksandra W. Debowski and Philippe Huot and has published in prestigious journals such as PLoS ONE, Chemical Communications and Gut.

In The Last Decade

Michael Gandy

25 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Gandy United Kingdom 14 150 116 115 80 76 25 532
Yeoun‐Hee Kim South Korea 16 278 1.9× 64 0.6× 80 0.7× 180 2.3× 73 1.0× 37 742
Masahiro Ohno Japan 15 282 1.9× 114 1.0× 57 0.5× 45 0.6× 12 0.2× 61 656
V. Cavett United States 17 624 4.2× 181 1.6× 94 0.8× 135 1.7× 51 0.7× 23 990
Jacques-Philippe Moulinoux France 16 403 2.7× 62 0.5× 60 0.5× 27 0.3× 44 0.6× 32 694
Pedro Brugarolas United States 13 272 1.8× 51 0.4× 26 0.2× 100 1.3× 29 0.4× 43 573
Jonathan Zuccolo Canada 11 222 1.5× 58 0.5× 54 0.5× 18 0.2× 37 0.5× 14 546
Aimee K. Bence United States 9 300 2.0× 38 0.3× 225 2.0× 28 0.3× 34 0.4× 21 591
L. Bokser United States 15 262 1.7× 69 0.6× 81 0.7× 35 0.4× 20 0.3× 25 752
Sung‐Fang Chen Taiwan 16 397 2.6× 25 0.2× 52 0.5× 55 0.7× 98 1.3× 50 692
Benjamin A. Belinka United States 12 188 1.3× 88 0.8× 38 0.3× 37 0.5× 16 0.2× 22 486

Countries citing papers authored by Michael Gandy

Since Specialization
Citations

This map shows the geographic impact of Michael Gandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gandy more than expected).

Fields of papers citing papers by Michael Gandy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gandy. The network helps show where Michael Gandy may publish in the future.

Co-authorship network of co-authors of Michael Gandy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gandy. A scholar is included among the top collaborators of Michael Gandy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gandy. Michael Gandy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Murray, Matthew J., Megan McIntosh, Claire Atkinson, et al.. (2021). Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay. Journal of Infection. 82(5). 170–177. 20 indexed citations
3.
Butt, Mohammed A., Hayley Pye, Rehan Haidry, et al.. (2017). Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate. Oncotarget. 8(15). 25080–25096. 20 indexed citations
4.
Gandy, Michael, et al.. (2015). An interactive database to explore herbicide physicochemical properties. Organic & Biomolecular Chemistry. 13(20). 5586–5590. 41 indexed citations
5.
Gandy, Michael, Colin L. Raston, & Keith A. Stubbs. (2014). Towards aryl C–N bond formation in dynamic thin films. Organic & Biomolecular Chemistry. 12(26). 4594–4594. 17 indexed citations
6.
Kapp, Joshua, Tim C. Diss, James Spicer, et al.. (2014). Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial. Journal of Clinical Pathology. 68(2). 111–118. 36 indexed citations
7.
Gandy, Michael, Lindsay T. Byrne, & Keith A. Stubbs. (2014). A simple and robust preparation of N-acetylindoxyls: precursors for indigogenic substrates. Organic & Biomolecular Chemistry. 13(3). 905–908. 5 indexed citations
8.
9.
Huot, Philippe, Tom H. Johnston, Michael Gandy, et al.. (2012). The Monoamine Re-Uptake Inhibitor UWA-101 Improves Motor Fluctuations in the MPTP-Lesioned Common Marmoset. PLoS ONE. 7(9). e45587–e45587. 36 indexed citations
10.
Starczynski, Jane, Neil Atkey, Fiona Campbell, et al.. (2012). HER2Gene Amplification in Breast Cancer. American Journal of Clinical Pathology. 137(4). 595–605. 58 indexed citations
11.
Johnston, Tom H., Philippe Huot, Sherri L. Thiele, et al.. (2012). A novel MDMA analogue, UWA‐101, that lacks psychoactivity and cytotoxicity, enhances l ‐DOPA benefit in parkinsonian primates. The FASEB Journal. 26(5). 2154–2163. 22 indexed citations
12.
Wasik, Agata M., Michael Gandy, Matthew J. McIldowie, et al.. (2011). Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (‘ecstasy’) through iterative chemical redesign: mechanisms and pathways to cell death. Investigational New Drugs. 30(4). 1471–1483. 5 indexed citations
13.
Bartlett, J. M. S., Jane Starczynski, Neil Atkey, et al.. (2011). HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods. Journal of Clinical Pathology. 64(8). 649–653. 56 indexed citations
14.
Gandy, Michael, Aleksandra W. Debowski, & Keith A. Stubbs. (2011). A general method for affinity-based proteomic profiling of exo-α-glycosidases. Chemical Communications. 47(17). 5037–5037. 20 indexed citations
15.
Gandy, Michael, Matthew Piggott, & Keith A. Stubbs. (2010). An Expeditious Synthesis of Iminosugars. Australian Journal of Chemistry. 63(10). 1409–1412. 10 indexed citations
16.
Gandy, Michael, Matthew J. McIldowie, Agata M. Wasik, et al.. (2010). Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity. MedChemComm. 1(4). 287–287. 12 indexed citations
17.
McIldowie, Matthew J., Michael Gandy, Brian W. Skelton, et al.. (2009). Physical and crystallographic characterisation of the mGlu5 antagonist MTEP and its monohydrochloride. Journal of Pharmaceutical Sciences. 99(1). 234–245. 3 indexed citations
18.
Słomiński, Andrzej, Igor Semak, Jordan K. Zjawiony, et al.. (2005). Enzymatic Metabolism of Ergosterol by Cytochrome P450scc to Biologically Active 17α,24-Dihydroxyergosterol. Chemistry & Biology. 12(8). 931–939. 57 indexed citations
19.
Peifer, John W., et al.. (2003). 3D visualization methods to guide surgery for Parkinson's disease.. PubMed. 94. 86–92. 2 indexed citations
20.
Robertson, W. R., et al.. (1984). Computerized continuous monitoring of cytochemical enzyme reaction product formation by the Vickers M85A microdensitometer. The Histochemical Journal. 16(6). 651–656. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yeoun‐Hee Kim Breakdown of academic impact, for papers by Masahiro Ohno Breakdown of academic impact, for papers by V. Cavett Breakdown of academic impact, for papers by Jacques-Philippe Moulinoux Breakdown of academic impact, for papers by Pedro Brugarolas Breakdown of academic impact, for papers by Jonathan Zuccolo Breakdown of academic impact, for papers by Aimee K. Bence Breakdown of academic impact, for papers by L. Bokser Breakdown of academic impact, for papers by Sung‐Fang Chen Breakdown of academic impact, for papers by Benjamin A. Belinka
Rankless by CCL
2026